Retrospective EHR study of 7,970 gout pts from Singapore finds ~28% are poorly controlled, with only 46% prescribed allopurinol (13% @doses ≥300). Poor control assoc w/ male gender (adj OR 1.66), Malay ethnicity (aOR 1.27), CHF (aOR, 1.64) https://t.co/M8dJFIbZEV https://t.co/aUnLgUmvXN

Cardiovascular manifestations of monogenic periodic fever syndromes - includes: - Pericarditis (most common) - Cardiac Amyloidosis - Myocarditis - CV complications of inflammation and steroid - Premature atherosclerosis https://t.co/iLfbPq2nzn https://t.co/T7Vtx5q8Y1

October is #PMR Month PMR has come a long way from being an occasional referral and often test question, to now being a hot area of drug development and investigation https://t.co/voVlxuRGZA https://t.co/NwEvws8cD3

RA QD Clinic - RA in Deep Remission If the patient is in Deep Remission - do you suggest DMARD or biologic weaning? https://t.co/ELV1MTNkrI https://t.co/9wiqvlZUEY

1 in 3 of our pts are on steroids; nice ARD full read review of important papers on steroids 2022-23 written by Prof J Bijlsma, covering: Mechanisms of action CV AE Bone Effects Infections, COVID-19 Clin trials Benefit vs Harm Tapering GC Guidelines https://t.co/MAErgj8MGz https://t.co/JDnBUU3FLe

Metanalysis of 17 studies (n=862849 pts) looked at fall risk w/ #OA. OA Hip (OR 1.50 & knee (OR 1.55) assoc w/ signif incr risk recurrent falls, but not FX. Xray knee OA w/ incr risk of falls (OR 1.28); Xray hip OA decr risk recurrent falls (OR 0.70) https://t.co/7iD8CDA1L7 https://t.co/Cn8lUt07WG

Long-term Safety of a JAKi in Patients with RA With up to 6.5 Years of Exposure View this poster on the long-term integrated safety data with a JAKi in patients with RA from 6 clinical studies. Sponsored by AbbVie US Medical Affairs https://t.co/h9hAaF5Q8d. https://t.co/RfhNioxQrm

ACR Comments on US Healthcare Policy The ACR said it has already joined with hundreds of organizations to submit 26 health policy comment letters to federal officials this year—surpassing the 24 letters the College submitted in 2022. https://t.co/5Jm3mVndNV https://t.co/DJVz45uV8k

Study of 3082 pts w/ muscle disease; 14 had adult IIM w/ myocarditis. Mean: 54 yrs, 71% black, Antisynthetase syndrome in 64% (Jo1=4, PL12=3); 79%) w/ active myositis, 93% hosp); 5 yr myocarditis survival 53% (6 died; all w/ LVEF < 40%) https://t.co/HChGMU2nBv https://t.co/36weNDoV97

NHANES study of >204 million persons finds 19.6% w/ hyperuricemia (HUC) & 4.1% w/ gout. Gout/HUC pts had higher tisk (HR 2.4) of heart failure (HF), expecially w/ age, DM, CV, & CAD risk factors, & w/ HF, 5-yr survival was 59.9% & 55.9% (1.4x ^ mortality) https://t.co/IrAUHcOV85 https://t.co/2AWhMES28g